About this trial
Achilles tendon rupture is common, yet the value of popliteal nerve block for postoperative pain control during surgical repair remains uncertain. Despite widespread use, evidence supporting its analgesic effectiveness is limited, and both popliteal nerve block and Achilles tendon repair carry risks of nerve injury. This randomized, placebo-controlled trial will evaluate whether adding a popliteal nerve block to standard systemic analgesia improves postoperative pain and reduces opioid use in patients undergoing acute Achilles tendon rupture repair. Secondary outcomes will examine the incidence and impact of nerve complications on recovery, including return to physical activity and functional performance.
Eligibility criteria
Qualifiers
Age 18 - 65
ASA classification: I - III
BMI < 35 kg/m2
Undergoing acute Achilles tendon rupture repair surgery as a day surgery procedure
Disqualifiers
Pre-existing neurological deficits or peripheral neuropathy in the distribution of the tibial or common peroneal nerves
Local infection
Contraindication to regional anesthesia (e.g., bleeding diathesis, coagulopathy)
History of use of over 30 mg oxycodone or equivalent per day
Trial design
Treatments tested in this trial
- Popliteal Nerve Block
- Sham Block